The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 9, Pages 2382
Publisher
MDPI AG
Online
2021-09-10
DOI
10.3390/cells10092382
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breaking the cycle: Targeting of NDRG1 to inhibit bi‐directional oncogenic cross‐talk between pancreatic cancer and stroma
- (2021) Bekesho Geleta et al. FASEB JOURNAL
- The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
- (2020) Lei Zhang et al. Molecular Cancer
- Neoadjuvant Treatment in Pancreatic Cancer
- (2020) Atsushi Oba et al. Frontiers in Oncology
- Iron Chelation Cancer Therapy Using Hydrophilic Block Copolymers Conjugated with Deferoxamine
- (2020) Kana Komoto et al. CANCER SCIENCE
- Iron and cancer: 2020 Vision
- (2020) Suzy V. Torti et al. CANCER RESEARCH
- E3 ubiquitin ligase Casitas B lineage lymphoma‐b and its potential therapeutic implications for immunotherapy
- (2020) D. Jafari et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Crystal and solution structure of NDRG1, a membrane‐binding protein linked to myelination and tumour suppression
- (2020) Venla Mustonen et al. FEBS Journal
- The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6
- (2019) Sharleen V. Menezes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death
- (2019) Ze Yu et al. CELL PROLIFERATION
- Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update
- (2019) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemoresistance in Pancreatic Cancer
- (2019) Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- OUP accepted manuscript
- (2018) ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- The role of TGF-β/SMAD4 signaling in cancer
- (2018) Ming Zhao et al. International Journal of Biological Sciences
- Phosphorylation of PI3K regulatory subunit p85 contributes to resistance against PI3K inhibitors in radioresistant head and neck cancer
- (2018) Myung Woul Han et al. ORAL ONCOLOGY
- Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
- (2018) Bahar Miraghazadeh et al. Frontiers in Immunology
- Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia
- (2018) Veronica Martini et al. Oncotarget
- Iron chelator-induced up-regulation of Ndrg1 inhibits proliferation and EMT process by targeting Wnt/β-catenin pathway in colon cancer cells
- (2018) Zhiqiang Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Metastasis Suppressor, NDRG1, Attenuates Oncogenic TGF-β and NF-ĸB Signaling to Enhance Membrane E-Cadherin Expression in Pancreatic Cancer Cells
- (2018) Sharleen V Menezes et al. CARCINOGENESIS
- The Roles of Autophagy in Cancer
- (2018) Chul Yun et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
- (2018) Andrew McGuigan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Src-family kinase-Cbl axis negatively regulates NLRP3 inflammasome activation
- (2018) I-Che Chung et al. Cell Death & Disease
- Overview of iron metabolism in health and disease
- (2017) Som Dev et al. Hemodialysis International
- TGF-β in pancreatic cancer initiation and progression: two sides of the same coin
- (2017) Wei Shen et al. Cell and Bioscience
- Activated HGF-c-Met Axis in Head and Neck Cancer
- (2017) Levi Arnold et al. Cancers
- Casitas B-lineage lymphoma linker helix mutations found in myeloproliferative neoplasms affect conformation
- (2016) Lori Buetow et al. BMC BIOLOGY
- Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation
- (2016) Christopher J. Tape et al. CELL
- TGF-β Signaling in Cancer
- (2016) Viqar Syed JOURNAL OF CELLULAR BIOCHEMISTRY
- A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC
- (2016) Nicole A Seebacher et al. Cell Death & Disease
- Nonfunctional Pancreatic Neuroendocrine Tumors: Advances in Diagnosis, Management, and Controversies
- (2015) Ersin Gürkan Dumlu et al. INTERNATIONAL SURGERY
- Di-2-pyridylketone 4,4-Dimethyl-3-thiosemicarbazone (Dp44mT) Overcomes Multidrug Resistance by a Novel Mechanism Involving the Hijacking of Lysosomal P-Glycoprotein (Pgp)
- (2015) Patric J. Jansson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter
- (2015) Nicole A. Seebacher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways
- (2015) Zaklina Kovacevic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the “Triad of Death” in cancer by Di-2-pyridylketone thiosemicarbazones
- (2015) Patric J. Jansson et al. PHARMACOLOGICAL RESEARCH
- The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1
- (2015) Wensheng Liu et al. Oncotarget
- Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition
- (2015) Shun Li et al. Scientific Reports
- Critical role of NF-κB in pancreatic cancer
- (2015) Lakshmi Prabhu et al. Oncotarget
- Expanding horizons in iron chelation and the treatment of cancer: Role of iron in the regulation of ER stress and the epithelial–mesenchymal transition
- (2014) Darius J.R. Lane et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Low Expression of the E3 Ubiquitin Ligase CBL Confers Chemoresistance in Human Pancreatic Cancer and Is Targeted by Epidermal Growth Factor Receptor Inhibition
- (2014) B. E. Kadera et al. CLINICAL CANCER RESEARCH
- Hypoxia induced changes in expression of proteins involved in iron uptake and storage in cultured lens epithelial cells
- (2014) Małgorzata Goralska et al. EXPERIMENTAL EYE RESEARCH
- The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of -catenin through mechanisms involving FRAT1 and PAK4
- (2014) R. Jin et al. JOURNAL OF CELL SCIENCE
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- Regulation of Wnt/β-catenin signaling by posttranslational modifications
- (2014) Chenxi Gao et al. Cell and Bioscience
- NF- B, an Active Player in Human Cancers
- (2014) Y. Xia et al. Cancer Immunology Research
- Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy
- (2013) Bernard A. Fang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Proteolytic cleavage and truncation of NDRG1 in human prostate cancer cells, but not normal prostate epithelial cells
- (2013) Mohammad K. Ghalayini et al. BIOSCIENCE REPORTS
- Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors
- (2013) J. Sun et al. CARCINOGENESIS
- The role of NDRG1 in the pathology and potential treatment of human cancers
- (2013) Dong-Hun Bae et al. JOURNAL OF CLINICAL PATHOLOGY
- N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion
- (2013) Darius J. R. Lane et al. PLoS One
- The lysosome: from waste bag to potential therapeutic target
- (2013) Hanna Appelqvist et al. Journal of Molecular Cell Biology
- The Iron-Regulated Metastasis Suppressor NDRG1 Targets NEDD4L, PTEN, and SMAD4 and Inhibits the PI3K and Ras Signaling Pathways
- (2012) Zaklina Kovacevic et al. ANTIOXIDANTS & REDOX SIGNALING
- Novel Chelators for Cancer Treatment: Where Are We Now?
- (2012) Angelica M. Merlot et al. ANTIOXIDANTS & REDOX SIGNALING
- Iron Chelators for the Treatment of Cancer
- (2012) Y. Yu et al. CURRENT MEDICINAL CHEMISTRY
- The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
- (2012) Antonella De Luca et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cancer and Radiation Therapy: Current Advances and Future Directions
- (2012) Rajamanickam Baskar et al. International Journal of Medical Sciences
- The Iron Chelators Dp44mT and DFO Inhibit TGF-β-induced Epithelial-Mesenchymal Transition via Up-Regulation of N-Myc Downstream-regulated Gene 1 (NDRG1)
- (2012) Zhiqiang Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo
- (2012) David B. Lovejoy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Desmoplasia in Pancreatic Cancer. Can We Fight It?
- (2012) E. E. Merika et al. Gastroenterology Research and Practice
- Antitumor Activity of Metal-Chelating Compound Dp44mT Is Mediated by Formation of a Redox-Active Copper Complex That Accumulates in Lysosomes
- (2011) D. B. Lovejoy et al. CANCER RESEARCH
- Novel Thiosemicarbazone Iron Chelators Induce Up-Regulation and Phosphorylation of the Metastasis Suppressor N-myc Down-Stream Regulated Gene 1: A New Strategy for the Treatment of Pancreatic Cancer
- (2011) Z. Kovacevic et al. MOLECULAR PHARMACOLOGY
- An overview of the c-MET signaling pathway
- (2011) Shawna Leslie Organ et al. Therapeutic Advances in Medical Oncology
- Assessment of the Evolution of Cancer Treatment Therapies
- (2011) Manuel Arruebo et al. Cancers
- The p85β regulatory subunit of PI3K serves as a substrate for PTEN protein phosphatase activity during insulin mediated signaling
- (2010) Jiman He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion
- (2010) Y Wu et al. BRITISH JOURNAL OF CANCER
- Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor Activity
- (2010) Patric J. Jansson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Metastasis mechanisms
- (2009) Thomas R. Geiger et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- N-myc Downstream Regulated Gene 1/Cap43 Suppresses Tumor Growth and Angiogenesis of Pancreatic Cancer through Attenuation of Inhibitor of B Kinase Expression
- (2009) F. Hosoi et al. CANCER RESEARCH
- Wnt Signaling Stimulates Transcriptional Outcome of the Hedgehog Pathway by Stabilizing GLI1 mRNA
- (2009) F. K. Noubissi et al. CANCER RESEARCH
- Desmoplasia of Pancreatic Ductal Adenocarcinoma
- (2009) Stephen Pandol et al. Clinical Gastroenterology and Hepatology
- Recent Advances in Cancer Therapy: An Overview
- (2009) A. Urruticoechea et al. CURRENT PHARMACEUTICAL DESIGN
- The TGF-β, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer
- (2008) Stephen J. Assinder et al. BIOCHEMICAL JOURNAL
- Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
- (2008) Anshul Gupte et al. CANCER TREATMENT REVIEWS
- Cellular signaling for activation of Rho GTPase Cdc42
- (2008) Soniya Sinha et al. CELLULAR SIGNALLING
- COPPER AND ANGIOGENESIS: UNRAVELLING A RELATIONSHIP KEY TO CANCER PROGRESSION
- (2008) Lydia Finney et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started